Coronavirus: Norway highlights new bleeding issues after AstraZeneca inoculations
- Bulgaria, Denmark, Iceland and Norway have already suspended use of the AstraZeneca vaccine while research is conducted into possible health problems
- ‘Something like this is rare, but very serious,’ said Steinar Madsen, head of Norway’s medicines agency
Three young people who received the coronavirus vaccine manufactured by AstraZeneca subsequently developed internal blood clots or bleeding in the brain, Norway's public health institute Folkehelseinstituttet said on Saturday.
All three work in health care, and the health agency said it would investigate whether there was a link.
“Something like this is rare, but very serious,” Steinar Madsen, head of Norway’s medicines agency, told broadcaster NRK.
The news out of Norway is the latest instance of health officials eyeing AstraZeneca’s Covid-19 vaccine nervously. Bulgaria, Denmark, Iceland and Norway have already suspended its use temporarily while research is conducted into possible health problems.
00:46
WHO investigates AstraZeneca Covid-19 vaccine after reports of blood clots
Multiple medical agencies, including the World Health Organization, have argued that the vaccine is safe. However, the worries about side effects are only compounding problems for the vaccine's reputation, which has suffered because of supply problems to the European Union.